======= CHORDC1 ======= == Gene Information == * **Official Symbol**: CHORDC1 * **Official Name**: cysteine and histidine rich domain containing 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=26973|26973]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UHD1|Q9UHD1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CHORDC1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CHORDC1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604353|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Regulates centrosome duplication, probably by inhibiting the kinase activity of ROCK2. Proposed to act as co-chaperone for HSP90. May play a role in the regulation of NOD1 via a HSP90 chaperone complex. In vitro, has intrinsic chaperone activity. This function may be achieved by inhibiting association of ROCK2 with NPM1. Involved in stress response. Prevents tumorigenesis. {ECO:0000269|PubMed:20230755}. |CS| |CHORD| |negative regulation of Rho-dependent protein serine/threonine kinase activity| |regulation of Rho-dependent protein serine/threonine kinase activity| |ADP binding| |Hsp90 protein binding| |regulation of centrosome duplication| |chaperone-mediated protein folding| |regulation of centrosome cycle| |regulation of cellular response to heat| |negative regulation of protein serine/threonine kinase activity| |regulation of microtubule cytoskeleton organization| |regulation of microtubule-based process| |negative regulation of protein kinase activity| |protein folding| |negative regulation of kinase activity| |negative regulation of transferase activity| |negative regulation of protein phosphorylation| |negative regulation of phosphorylation| |cellular component| |regulation of protein serine/threonine kinase activity| |regulation of cytoskeleton organization| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |negative regulation of protein modification process| |regulation of cellular response to stress| |regulation of cell cycle process| |negative regulation of catalytic activity| |regulation of protein kinase activity| |zinc ion binding| |regulation of kinase activity| |regulation of transferase activity| |negative regulation of cellular protein metabolic process| |negative regulation of protein metabolic process| |negative regulation of molecular function| |regulation of cell cycle| |regulation of organelle organization| |regulation of protein phosphorylation| |regulation of response to stress| |ATP binding| |regulation of phosphorylation| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of protein modification process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp46|HMS-I1 1μM R01 exp46]]|-1.81| |[[:results:exp487|Hinokiflavone 12μM R08 exp487]]|1.7| ^Gene^Correlation^ |[[:human genes:t:thg1l|THG1L]]|0.467| |[[:human genes:h:hars|HARS]]|0.452| |[[:human genes:u:uap1|UAP1]]|0.451| |[[:human genes:g:gfpt1|GFPT1]]|0.434| |[[:human genes:r:rnmt|RNMT]]|0.42| |[[:human genes:d:dhps|DHPS]]|0.412| |[[:human genes:r:rptor|RPTOR]]|0.411| |[[:human genes:g:gmppb|GMPPB]]|0.41| |[[:human genes:o:oraov1|ORAOV1]]|0.409| |[[:human genes:t:triap1|TRIAP1]]|0.409| |[[:human genes:t:tgs1|TGS1]]|0.407| |[[:human genes:p:pmm2|PMM2]]|0.4| Global Fraction of Cell Lines Where Essential: 460/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|1/1| |bile duct|17/28| |blood|19/28| |bone|16/26| |breast|21/33| |central nervous system|32/56| |cervix|3/4| |colorectal|11/17| |esophagus|11/13| |fibroblast|1/1| |gastric|10/16| |kidney|8/21| |liver|14/20| |lung|46/75| |lymphocyte|10/16| |ovary|11/26| |pancreas|19/24| |peripheral nervous system|8/16| |plasma cell|9/15| |prostate|0/1| |skin|13/24| |soft tissue|4/9| |thyroid|1/2| |upper aerodigestive|16/22| |urinary tract|25/29| |uterus|2/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1472 * **Expression level (log2 read counts)**: 7.07 {{:chemogenomics:nalm6 dist.png?nolink |}}